# Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

> **NCT02425579** · PHASE1 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 12 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)

## Interventions

- **DRUG:** Inhaled Carbon Monoxide at 100ppm (4 participants)
- **DRUG:** Placebo for Inhaled Carbon Monoxide at 100ppm (2 participants)
- **DRUG:** Inhaled Carbon Monoxide at 200ppm (4 participants)
- **DRUG:** Placebo for Inhaled Carbon Monoxide at 200ppm (2 participants)

## Key facts

- **NCT ID:** NCT02425579
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-10-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02425579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02425579, "Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02425579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*